Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany15307-86-5 98%
Diclofenac
Diclofenac
Diclofenac

15307-86-5 98%

Price Get Latest Price
Packge 1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-11

Product Details

  • Product NameDiclofenac
  • CAS No.15307-86-5
  • EINECS No.239-348-5
  • MFC14H11Cl2NO2
  • MW296.15
  • Appearancepowder to crystalWhite to Almost white
  • Melting point 156-158°
  • Boiling point 412.0±45.0 °C(Predicted)
  • density 1.431±0.06 g/cm3(Predicted)
  • Water Solubility 1.278mg/L(30 ºC)
  • storage temp. Sealed in dry,Room Temperature

Company Profile Introduction

Refsyn Biosciences Pvt Ltd is an ISO 9001:2008 certified company, registered under Government of Puducherry & approved by Ministry of Corporate Affairs, Government of India by the companies act, 1956 (No. 1 of 1956), corporate identify number: U74900PY2012PTC002664 established in India in 2012. Refsyn is situated in heart of the Puducherry, one of the most popular tourist spots. We have around 2,000 sq. ft. laboratory space with sophisticated instruments.

Refsyn Biosciences is an innovative leading contract research organization (CRO), focus on specializing in custom synthesis and provide research services for the Pharmaceutical, Biotechnology and Agrochemical industries on a contract basis. Our team support for the research, development and synthesis of Active pharmaceutical Ingredients (APIs) related substances, Impurities, Metabolites, Internal Standards at Milligram scale. We are specialized in the synthesis of hydroxy, demethylated, N-oxide and glucuronide metabolites, which are essential for their structural confirmation and pharmacologic/toxicological/ Agrochemical characterization.

Refsyn Biosciences Pvt Ltd

1Y Tamil Nadu India
  • Since:2020-01-01
  • Address: "No.28, 3rd Cross street,_x000D_ Natesan Nagar(West), Puducherry-605005, India."
INQUIRY